St. Paul's Hospital Emergency Department
Vancouver, British Columbia, V6Z 1Y6, Canada
NCT Number: NCT03375671
Compare intramuscular (IM) ketamine to a combination of IM midazolam and haloperidol with regards to the time required for adequate behavioral control, in minutes, in patients presenting to the emergency department with psychomotor agitation and violent behavior.
Looking for future studies?
Notify Me19 year–60 year
All sexes
Interventional
Phase 2
Vancouver, British Columbia, V6Z 1Y6, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
single administration of 5 mg/kg, IM
Other names: ketamine
single administration of 5 mg, IM
single administration of 5 mg, IM
Time frame: 1 day
Measured using Richmond Agitation Sedation Scale (RASS) in each arm
Time frame: up to 4 days
measured by AE collection in each arm
Time frame: 1 day
measured by rescue medication administration
Time frame: 1 day
measured using Tracking and Reporting Outcomes of Procedural Sedation (TROOPS) criteria
Time frame: 1 day
measured by occurrence of neuroleptic malignant syndrome
Time frame: 1 day
measured by police account at study enrollment
Time frame: 1 day
measured using Participant Experience Survey
Time frame: 1 day
measured using Study Nurse Experience Survey
Time frame: 1 day
measured using Effectiveness of Study Drug Blinding Survey
David Barbic
Other
Rapid Agitation Control With Ketamine in the Emergency Department (RACKED): a Randomized Controlled Trial
Acronym: RACKED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03139110
Aberrant Motor Behavior in Dementia, Aggression
Lyon, France
View Trial DetailsNCT07416669
Aberrant Motor Behavior in Dementia, Aggression
Witten, Germany
View Trial DetailsNCT02015884
Aberrant Motor Behavior in Dementia, Aggression
Lyon, France
View Trial DetailsNCT07728162
Diabetes Mellitus, Disease Attributes
Bolu, Turkey (Türkiye)
View Trial Details